Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Yongwhan Choi"'
Autor:
Man Kyu Shim, Suah Yang, Jooho Park, Jun Sik Yoon, Jinseong Kim, Yujeong Moon, Nayeon Shim, Mihee Jo, Yongwhan Choi, Kwangmeyung Kim
Publikováno v:
Journal of Nanobiotechnology, Vol 20, Iss 1, Pp 1-15 (2022)
Abstract Background Nanomedicine has emerged as a promising strategy for cancer treatment. The most representative nanomedicine used in clinic is PEGylated liposomal doxorubicin DOXIL®, which is first FDA-approved nanomedicine. However, several shor
Externí odkaz:
https://doaj.org/article/1d964f4c8c194484a709a371bc75bf02
Publikováno v:
Pharmaceutics, Vol 14, Iss 9, p 1908 (2022)
Various immunotherapeutic agents that can elicit antitumor immune responses have recently been developed with the potential for improved efficacy in treating cancer. However, insufficient delivery efficiency at the tumor site, along with severe side
Externí odkaz:
https://doaj.org/article/2ab5eda442c54bf5965cb9907be29730
Autor:
Jeongrae Kim, Yongwhan Choi, Suah Yang, Jaewan Lee, Jiwoong Choi, Yujeong Moon, Jinseong Kim, Nayeon Shim, Hanhee Cho, Man Kyu Shim, Sangmin Jeon, Dong-Kwon Lim, Hong Yeol Yoon, Kwangmeyung Kim
Publikováno v:
Pharmaceutics, Vol 14, Iss 3, p 474 (2022)
Immunogenic cell death (ICD) is a powerful trigger eliciting strong immune responses against tumors. However, traditional chemoimmunotherapy (CIT) does not last long enough to induce sufficient ICD, and also does not guarantee the safety of chemother
Externí odkaz:
https://doaj.org/article/43e2445e935f492f9acd0bf5364d94ef
Autor:
Yongwhan Choi, Hong Yeol Yoon, Jeongrae Kim, Suah Yang, Jaewan Lee, Ji Woong Choi, Yujeong Moon, Jinseong Kim, Seungho Lim, Man Kyu Shim, Sangmin Jeon, Ick Chan Kwon, Kwangmeyung Kim
Publikováno v:
Pharmaceutics, Vol 12, Iss 12, p 1165 (2020)
Direct local delivery of immunogenic cell death (ICD) inducers to a tumor site is an attractive approach for leading ICD effectively, due to enabling the concentrated delivery of ICD inducers to the tumor site. Herein, we prepared doxorubicin (DOX)-l
Externí odkaz:
https://doaj.org/article/b557bfffd5504c519107f53be6d6ea42
Autor:
Yongwhan Choi, Hyounkoo Han, Sangmin Jeon, Hong Yeol Yoon, Hyuncheol Kim, Ick Chan Kwon, Kwangmeyung Kim
Publikováno v:
Pharmaceutics, Vol 12, Iss 10, p 974 (2020)
The dense extracellular matrix (ECM) in heterogeneous tumor tissues can prevent the deep tumor penetration of drug-loaded nanoparticles, resulting in a limited therapeutic efficacy in cancer treatment. Herein, we suggest that the deep tumor penetrati
Externí odkaz:
https://doaj.org/article/6d8d971bfa6442269cf85663aec57061
Publikováno v:
Theranostics
The use of nanomedicine for cancer treatment takes advantage of its preferential accumulation in tumors owing to the enhanced permeability and retention (EPR) effect. The development of cancer nanomedicine has promised highly effective treatment opti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6af10fffcedb916f269b5122339a9511
http://europepmc.org/articles/PMC6857053
http://europepmc.org/articles/PMC6857053
Publikováno v:
Expert Opinion on Drug Delivery. 16:835-846
Introduction: In the past decade, the glycol chitosan nanocarriers (GCNCs) have been widely used for tumor-targeted delivery of anticancer agents such as chemo drugs, peptides, and genes du...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e434530d4919402684f584f0139ee57f
https://doi.org/10.1080/17425247.2019.1648426
https://doi.org/10.1080/17425247.2019.1648426
Autor:
Hong Yeol Yoon, Kwangmeyung Kim, Hyounkoo Han, Yongwhan Choi, Sangmin Jeon, Hyuncheol Kim, Ick Chan Kwon
Publikováno v:
Pharmaceutics, Vol 12, Iss 974, p 974 (2020)
Pharmaceutics
Volume 12
Issue 10
Pharmaceutics
Volume 12
Issue 10
The dense extracellular matrix (ECM) in heterogeneous tumor tissues can prevent the deep tumor penetration of drug-loaded nanoparticles, resulting in a limited therapeutic efficacy in cancer treatment. Herein, we suggest that the deep tumor penetrati
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fe4259b1919f70f475347caec0385a3b
https://www.mdpi.com/1999-4923/12/10/974
https://www.mdpi.com/1999-4923/12/10/974
Autor:
Ji Young Yhee, Jin Hee Na, Dong Gil You, Kwangmeyung Kim, Ju Hee Ryu, Jae Hyung Park, Kuiwon Choi, Hyeyoun Chang, Yongwhan Choi, Kwan Hyi Lee, Gun Hyuk Jang, Ick Chan Kwon
Publikováno v:
Journal of Controlled Release. 244:205-213
Nanoparticles have resulted in great progress in biomedical imaging and targeted drug delivery in cancer theranostics. To develop nanoparticles as an effective carrier system for therapeutics, chemical structures and physicochemical properties of nan
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::22e8dda1aa62b551c74eb941083dce70
https://doi.org/10.1016/j.jconrel.2016.07.025
https://doi.org/10.1016/j.jconrel.2016.07.025
Autor:
Jeongrae Kim, Kwangmeyung Kim, Ick Chan Kwon, Seungho Lim, Jiwoong Choi, Jaewan Lee, Sangmin Jeon, Hong Yeol Yoon, Jinseong Kim, Yujeong Moon, Man Kyu Shim, Yongwhan Choi, Suah Yang
Publikováno v:
Pharmaceutics, Vol 12, Iss 1165, p 1165 (2020)
Pharmaceutics
Volume 12
Issue 12
Pharmaceutics
Volume 12
Issue 12
Direct local delivery of immunogenic cell death (ICD) inducers to a tumor site is an attractive approach for leading ICD effectively, due to enabling the concentrated delivery of ICD inducers to the tumor site. Herein, we prepared doxorubicin (DOX)-l
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c83364e69cd87de2212ecf661557f385
https://doi.org/10.3390/pharmaceutics12121165
https://doi.org/10.3390/pharmaceutics12121165